- Board of Directors
- Corporate Governance Advisory Council
- Markets Advisory Council
- CII Staff
- Press Releases
Institutional Investors Oppose Stitch Fix Dual-Class Structure but Welcome Sunset Provision Uber’s Governance — Investor Response Do Not Disadvantage US Investors on Research,
CII Asks SEC
CII Fall Conference, September 13-15, San Diego CII Welcomes S&P Dow Jones’ Decision to Ban New Multi-Class Companies from Key Stock Indexes CII Applauds FTSE Russell Decision to Set Voting Rights
Minimum for Inclusion on Indexes
Investor Group Urges Blue Apron to Ditch No-Vote Shares Institutional Investors Dismayed by House Passage of
Financial CHOICE Act
CII, Institutional Investors with $4+ Trillion in Assets Oppose
Anti-Shareholder Provisions of the CHOICE Act
Council of Institutional Investors Executive Director Ken Bertsch Testifies on the Financial CHOICE Act Institutional Investors Oppose Key Provisions
of the Financial CHOICE Act
- CII in the News
- Governance & Financial Information
- Join & Support
- Contact Us
Do Not Disadvantage US Investors on Research,
CII Asks SEC
CII Asks SEC
Washington, D.C., Sept. 22, 2017 — The Council of Institutional Investors on September 22 sent a letter to Securities and Exchange Commission Chairman Jay Clayton, requesting that the Commission work to permit U.S. investment managers and asset owners to “unbundle” their trade execution from research. Effective January, the European Union’s MiFID II directive will require investment managers to pay for research services directly, either from their own funds or from an account funded by clients.
CII understands that some broker-dealers are seeking SEC relief for European clients, permitting them to directly pay for research. These broker-dealers apparently will continue to force bundling of research for U.S. investors.
“The SEC should seek to create a clear path for unbundling of research from trade execution, for all investors, including those domiciled in the United States” said CII General Counsel Jeff Mahoney. Mahoney said that separation of cost of trade execution from research would increase transparency and price discovery for trade execution and the cost of research, reduce investor costs through more efficient markets for research, and encourage independent research. He added that if universal no-action relief consistent with CII’s approach is not feasible at this time, it is important that any no-action relief granted be temporary and “promptly followed” by Commission action with appropriate public due process that results in a better approach for all investors.
Click for PDF version. For media inquiries, please contact CII Executive Director Ken Bertsch.